Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 29.10.2024
Sage Therapeutics Мультипликаторы 2011-2024 | SAGE
Мультипликаторы по годам Sage Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.8 | -5.0 | -5.5 | 7.4 | -5.0 | -16.4 | -26.1 | -9.7 | -9.9 | -25.8 | - | - | - |
P/S |
17.8 | 344.8 | 395.7 | 4.0 | 494.5 | 67.8 | - | - | - | - | - | - | - |
EPS |
-9.1 | -9.0 | -7.8 | 11.7 | -13.4 | -8.1 | -7.1 | -4.8 | -3.4 | -1.7 | -12.3 | -8.6 | - |
EV (Enterprise Value) |
1.55 млрд | 2.59 млрд | 2.3 млрд | 2.92 млрд | 3.41 млрд | 6.02 млрд | 6.79 млрд | 1.41 млрд | 761 млн | 751 млн | 32 млн | 13.6 млн | - |
EBITDA per Share |
-9.67 | -9.2 | -7.78 | 11.5 | -13.9 | -8.5 | -7.15 | -4.77 | -3.4 | -1.56 | - | - | - |
EV/EBITDA |
-5.0 | 4.1 | -4.6 | -15.1 | -24.7 | -8.6 | -7.9 | -22.0 | - | - | - | ||
PEG |
0.05 | 0.1 | 0.12 | -3.48 | 0.08 | 1.18 | 0.53 | 0.24 | 0.1 | -1.98 | - | - | - |
P/B |
1.9 | 2.1 | 1.4 | 2.2 | 3.6 | 7.1 | 14.8 | 4.2 | 5.4 | 7.1 | - | - | - |
P/CF |
-2.8 | -5.8 | -6.6 | 6.8 | -6.4 | -23.2 | -31.9 | -12.8 | -13.2 | -32.1 | - | - | - |
ROE % |
-67.73 | -42.53 | -26.48 | 29.25 | -72.01 | -43.21 | -56.81 | -43.14 | -54.40 | -27.74 | - | - | - |
ROA % |
-61.37 | -39.28 | -25.09 | 28.07 | -62.74 | -39.14 | -50.97 | -39.30 | -49.99 | -26.08 | - | - | - |
ROCE % |
-72.52 | -43.67 | -26.66 | 28.77 | -72.85 | -45.37 | -57.15 | -43.36 | -54.49 | -27.73 | - | - | - |
Current Ratio |
10.7 | 13.1 | 19.0 | 24.8 | 9.2 | 11.0 | 10.1 | 11.4 | 12.3 | 16.6 | - | - | - |
DSO |
204.1 | 324.3 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 13930.2 | - | - | - | - | - | - | - | - |
Операционный цикл |
204.1 | 324.4 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
204.1 | 324.4 | - | - | -13930.2 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Sage Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.53 | -1.7 | -1.8 | - | -3.37 | -2.68 | -2.46 | - | -2.31 | -2.13 | -2.07 | - | -2.21 | -1.83 | -1.64 | 18.71 | -2.03 | -2.63 | -2.44 | -3.25 | -3.48 | -3.28 | -3.37 | -3.38 | -2.63 | -0.36 | -1.68 | -1.75 | -1.97 | -1.88 | -1.52 | -1.5 | -1.15 | -1.08 | -0.97 | -0.99 | -0.84 | -0.9 | -0.66 | -0.48 | -0.5 | -4.57 | -3.7 | - | -2.98 | -3.18 | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.95 | - | - | - | -2.6 | - | -2.37 | -2.17 | -2.08 | - | -2.16 | -1.83 | -1.61 | 16.7 | -2.05 | -2.66 | -2.52 | -3.37 | -3.61 | -3.43 | -3.49 | -3.5 | -2.75 | -0.47 | -1.76 | -1.68 | -1.98 | -1.89 | -1.53 | -1.51 | -1.15 | -1.09 | -0.97 | -0.99 | -0.84 | -0.9 | -0.66 | -0.48 | -0.48 | -3.63 | -3.5 | - | -2.96 | -3.16 | - | - | - | - | - | - | - | - | - |
ROE % |
-73.39 | -81.13 | -81.04 | -53.93 | -63.88 | -49.14 | -41.25 | -25.88 | -32.98 | -30.12 | -27.28 | -17.43 | 29.61 | 31.60 | 30.58 | 29.25 | -35.65 | -49.60 | -60.83 | -72.01 | -72.51 | -67.70 | -51.86 | -43.21 | -39.46 | -40.72 | -53.51 | -56.81 | -57.38 | -52.13 | -46.80 | -43.14 | -44.42 | -48.00 | -52.98 | -54.40 | -48.10 | -42.03 | -32.70 | -27.74 | -3.27 | 18.83 | 38.67 | 29.09 | 29.09 | 14.76 | - | - | - | - | - | - | - | - | - |
ROA % |
-65.15 | -71.35 | -71.41 | -48.07 | -57.31 | -45.32 | -37.67 | -23.55 | -30.31 | -20.66 | -25.99 | -16.68 | 28.47 | 30.33 | 29.34 | 28.07 | -32.64 | -44.34 | -53.54 | -62.74 | -63.81 | -60.12 | -46.38 | -39.14 | -35.61 | -36.62 | -48.09 | -50.97 | -51.69 | -47.12 | -42.47 | -39.30 | -40.59 | -43.97 | -48.62 | -49.99 | -44.42 | -39.00 | -30.54 | -26.08 | -69.51 | -115.17 | -164.96 | -107.52 | -107.52 | -54.56 | - | - | - | - | - | - | - | - | - |
ROCE % |
-78.67 | -86.28 | -85.87 | -56.98 | -67.23 | -51.54 | -42.76 | -26.40 | -33.53 | -30.41 | -27.47 | -17.55 | 29.45 | 31.41 | 30.30 | 28.77 | -36.72 | -51.36 | -63.33 | -74.96 | -75.50 | -70.61 | -54.50 | -45.57 | -41.35 | -42.08 | -54.41 | -57.45 | -57.93 | -52.62 | -47.22 | -43.46 | -44.64 | -48.17 | -53.10 | -54.49 | -48.16 | -42.07 | -32.72 | -27.74 | -3.27 | 18.83 | 38.67 | 29.09 | 29.09 | 14.76 | - | - | - | - | - | - | - | - | - |
Current Ratio |
8.8 | 10.1 | 12.4 | 10.7 | 7.1 | 11.1 | 13.9 | 13.1 | 14.0 | - | 19.6 | 19.0 | 21.1 | 23.4 | 26.9 | 24.8 | 24.8 | 24.8 | 24.8 | 7.8 | 7.8 | 7.8 | 7.8 | 10.6 | 10.6 | 10.6 | 10.6 | 9.7 | 9.7 | 9.7 | 9.7 | 11.2 | 11.2 | 11.2 | 11.2 | 12.3 | 12.3 | 12.3 | 12.3 | 16.7 | 16.7 | 16.7 | 16.7 | 3.6 | 3.6 | 3.6 | - | - | - | - | - | - | - | - | - |
DSO |
95.4 | 107.8 | 540.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.3 | 9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31659.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
95.4 | 107.8 | 540.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.3 | 9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
95.4 | 107.8 | 540.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -31659.6 | - | - | 9.3 | 9.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD